Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1573387450387035136
  • NII Article ID
    10021293574
  • Data Source
    • CiNii Articles

Report a problem

Back to top